4.6.1.14	2-deoxy-2-fluoro-scyllo-inositol-1-O-dodecyl-phosphonic acid	GPI-1793	57855	
4.6.1.14	Ca2+	activity of GPI-PLC exhibited small but significant inhibition in the presence of calcium ions, 70% activity left	15	
4.6.1.14	Ca2+	weak, 5 mM	15	
4.6.1.14	cetrimide	i.e. alkyltrimethylammonium bromide, 0.3 mg/ml, neutral enzyme form	43910	
4.6.1.14	deoxycholate	neutral enzyme form, above 1 mg/ml, activation at 0.5-1 mg/ml	441	
4.6.1.14	EDTA	-	21	
4.6.1.14	EGTA	Ca2+ reverses, only acidic, not neutral enzyme form	173	
4.6.1.14	EGTA	-	173	
4.6.1.14	Glucosaminyl-alpha-1,6-2-deoxy-D-myo-inositol	i.e. compound VP-615L, more effective than VP-606L	93496	
4.6.1.14	Glucosaminyl-alpha-1,6-D-myo-inositol	i.e. compound VP-606L or 6-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol	93497